This Article Full Text (PDF) Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ward, W. F. Articles by Hinz, J. M. Search for Related Content PubMed PubMed Citation Articles by Ward, W. F. Articles by Hinz, J. M.

The effect of Captopril on benign and malignant reactions in irradiated rat skin

W. F. Ward, PhD ^* A. Molteni, MD, PhD C. Ts'ao, PhD and J. M. Hinz, BS ^*

^* Department of Radiology, Northwestern University Medical School, Chicago, IL 60611, USA Department of Pathology, Northwestern University Medical School, Chicago, IL 60611, USA

The effect of the angiotensin converting enzyme inhibitor Captopril on the severity of radiation-induced epilation and moist desquamation and the incidence of skin tumours was determined for up to 52 weeks in male rats. The irradiation consisted of a range of single doses (0, 10, 20, 30 Gy) of ⁶⁰Co gamma rays to a 3.5 cm² right hemithorax port. Half of each radiation dose group consumed control powdered chow, and half consumed chow containing Captopril (50 mg/kg/day) continuously after irradiation. There were time- and radiation-dose-dependent increases in all three skin reactions. Rats exposed to 10 Gy exhibited a mild and transient epilation, but no moist desquamation or neoplasia in the radiation port. In animals exposed to 30 Gy, however, epilation began at 2 weeks after irradiation, reached a peak at approximately 7 weeks, then persisted essentially unchanged through 52 weeks. Captopril had no significant effect on the epilation reaction. Two waves of moist desquamation were observed after 30 Gy. The first appeared at 3 weeks after irradiation, reached a peak from 6–10 weeks, then subsided partially but significantly from 12–26 weeks. The second wave of moist desquamation began at 26–28 weeks, often was ulcerative, and occasionally was accompanied by the appearance of tumours in the irradiated volume. Captopril significantly (p <0.05) reduced the severity of both phases of the moist desquamation reaction after 30 Gy, and reduced the percentage of animals exhibiting the most severe desquamation score (involving 50% of the radiation port). Of particular interest was the observation that Captopril also reduced the incidence of tumours. Of the 14 tumours detected, all were malignant (fibrosarcomas, squamous cell carcinomas), and only three (p <0.05) occurred in rats receiving Captopril. Multiple tumours (three cases), tumours induced by 20 Gy (three cases), and tumours appearing before 6 months (one case) were observed only in rats consuming control diet, never in Captopriltreated animals. Animals which developed tumours in the second 6 months post-irradiation exhibited significantly more severe moist desquamation during the first 6 months than did the tumour-free members of their treatment group. Thus Captopril, known to ameliorate acute lung damage in irradiated rats, also reduces chronic benign and malignant skin reactions in the radiation treatment field.

Received for publication September 1, 1989. Revision received November 1, 1989.

This article has been cited by other articles:

				P. J. Wysocki, E. P. Kwiatkowska, U. Kazimierczak, W. Suchorska, D. W. Kowalczyk, and A. Mackiewicz Captopril, an Angiotensin-Converting Enzyme Inhibitor, Promotes Growth of Immunogenic Tumors in Mice. Clin. Cancer Res., July 1, 2006; 12(13): 4095 - 4102. [Abstract] [Full Text] [PDF]

				B.D. Uhal Epithelial apoptosis in the initiation of lung fibrosis Eur. Respir. J., September 20, 2003; 22(44_suppl): 7s - 9s. [Full Text] [PDF]

				F Candan and H Alagozlu Captopril inhibits the pulmonary toxicity of paraquat in rats Human and Experimental Toxicology, December 1, 2001; 20(12): 637 - 641. [Abstract] [PDF]

				E Grossman, F.H Messerli, and U Goldbourt Antihypertensive therapy and the risk of malignancies Eur. Heart J., August 1, 2001; 22(15): 1343 - 1352. [Abstract] [PDF]

				R. Wang, O. Ibarra-Sunga, L. Verlinski, R. Pick, and B. D. Uhal Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor Am J Physiol Lung Cell Mol Physiol, July 1, 2000; 279(1): L143 - L151. [Abstract] [Full Text] [PDF]

				F. D. Malkinson Radiation Injury to Skin Following Fluoroscopically Guided Procedures Arch Dermatol, June 1, 1996; 132(6): 695 - 696. [Abstract] [PDF]